BioAge Labs (BIOA) Other Non Operating Income (2024)

BioAge Labs' (BIOA) quarterly Other Non Operating Income came in at -$250000.0 in Q1 2024.

BioAge Labs (BIOA) Other Non Operating Income (2024) Analysis & Trends

BioAge Labs has disclosed Other Non Operating Income across 1 years of filings, most recently posting -$250000.0 for Q1 2024.

  • Other Non Operating Income for Q1 2024 came in at -$250000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$250000.0 (changed N/A YoY), and the FY2024 annual result was -$250000.0, changed N/A from the prior year.
  • Other Non Operating Income came in at -$250000.0 for Q1 2024 at BioAge Labs.
  • In the past five years, Other Non Operating Income ranged from a high of -$250000.0 in Q1 2024 to a low of -$250000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 BioAge Labs 671.19 Mn 288.00 Mn -10.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 -250,000.00